Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Issue Archive
Events
MM&M Awards 2012
Webcasts
MM&M Virtual Summit
Whitepapers
Directories
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Television
P&G signals plans to cut ad costs by shifting to digital media
Matthew Arnold
February 01, 2012
Procter & Gamble is looking to lower its promotion costs by leaning more on digital media, Chairman and CEO Bob McDonald told analysts in an earnings call.
FDA study casts doubt on danger of "distracting visuals"
Matthew Arnold
January 31, 2012
An FDA study looking at the power of background visuals to distract viewers from the often-ominous risk info read in the "major statement" section of TV drug ads found no evidence that consumer understanding of risk info is affected by the "emotional (affective) tone of images.
Bon Jovi enlists in Advil's battle with Tylenol
Matthew Arnold
December 21, 2011
Jon Bon Jovi is the latest celebrity pitchman for Pfizer Consumer Healthcare's Advil.
Ethnically insensitive Summer's Eve ads draw eyeballs and brickbats
Matthew Arnold
July 20, 2011
A feminine hygiene brand known for its boffo advertising is back with an anatomically-explicit ad campaign that's generating tons of publicity but also charges of racism.
Network TV show in the works for Everyday Health
Matthew Arnold
July 11, 2011
Everyday Health is planting its flag in network television with an ABC show that is being produced by "The Biggest Loser" creator Mark Koops.
Pradaxa DTC goes the white coat route
Matthew Arnold
May 09, 2011
Boehringer Ingelheim is launching its Pradaxa DTC campaign with a first wave of white-coated doctors talking up the blood thinner for atrial fibrillation.
Roche maintained DTC spending on Boniva, while competitors cut back
Ben Comer
March 03, 2011
Sally Field's winsome smile may have helped to curb declining sales of Roche's Boniva in 2010, but it didn't carry the drug past Warner Chilcott's Actonel, despite a substantially higher DTC spend.
To dial down DTC, let companies collaborate on ads, says ex-Merck exec
Matthew Arnold
February 10, 2011
A former Merck exec says it's time to wind down the DTC arms race by letting companies with brands in competitive categories collaborate on disease awareness advertising.
GSK launches new Alli spots, hands five OTC brands to Meda
Ben Comer
January 05, 2011
GlaxoSmithKline launched new commercials for Alli, in time for New Year's resolutions and holiday overeating remorse, and handed off five OTC products to Meda Pharmaceuticals.
Lysteda TV ads make some networks squeamish
Matthew Arnold
October 20, 2010
Ferring Pharmaceuticals is launching its first branded TV ad with spots for its Lysteda treatment for heavy menstrual bleeding. The company had to soothe some network execs who at first balked at the ad's blunt talk of the condition.
Ads about family health risk prompt lifestyle changes
Matthew Arnold
August 24, 2010
Drug ads emphasizing familial health risks prompt at-risk patients to adjust their lifestyles, not just pop a pill, a study found.
Bayer unbranded effort aims to counter bad birth control info
Matthew Arnold
June 30, 2010
Bayer wants women to come to the company for information on contraception instead of relying on coworkers, bloggers or the tube for advice.
NASCAR driver Jeff Gordon to lead Sanofi whooping cough awareness campaign
Ben Comer
June 30, 2010
In an effort to throttle up awareness of whooping cough, or pertussis, Sanofi Pasteur and the March of Dimes have enlisted NASCAR driver Jeff Gordon to lead their ongoing Sounds of Pertussis campaign. Jennifer Lopez was previously the celebrity face of the campaign.
Nicorette launch features Facebook contest with Dr. Drew
Matthew Arnold
April 28, 2010
GlaxoSmithKline is launching a Nicorette lozenge with a new iteration of the "Quitting Sucks" ad campaign and a Facebook contest starring TV shrink Dr. Drew Pinsky.
GSK rolls out new DTC ads for Lovaza
Ben Comer
April 06, 2010
GlaxoSmithKline launched new TV spots last week for Lovaza, a prescription omega-3 fish oil capsule indicated for the lowering of very high triglyceride levels.
Aricept TV spots hype benefits, says DDMAC
Matthew Arnold
February 24, 2010
Eisai got an FDA untitled letter for two Aricept TV ads that the agency said overstate the efficacy of the drug.
Nexium ad campaign promises nighttime relief
Matthew Arnold
February 03, 2010
AstraZeneca is answering OTC Prevacid with ads touting Nexium's nighttime benefits and taking a comical look at the lengths to which acid reflux sufferers will go for a good night's sleep.
AstraZeneca airs "consuming" consumer for Seroquel XR bipolar depression
Matthew Arnold
December 17, 2009
AstraZeneca launched the first consumer TV and print ads for Seroquel XR for bipolar depression, playing on the all-consuming way in which patients experience the disease.
Hey, big spender! Pfizer joins top 10 advertisers
Matthew Arnold
December 08, 2009
Pfizer boosted ad spend 12% for the first nine months of 2009 over the same period in 2008, even as ad spend for the sector remained static and spending across all sectors plummeted 14.7%, according to TNS Media Intelligence.
Info overloaded, consumers tune out risk info, says survey
Matthew Arnold
November 30, 2009
Consumers tend to block out risk info in TV and print ads for prescription drugs -- particularly those over age 55 -- according to a study by ORC Guideline.
In DTC TV, longer doesn't have to mean less memorable, says Nielsen
Matthew Arnold
November 05, 2009
Prescription drug advertisers are running longer broadcast spots to accommodate more expansive fair balance statements, a Nielsen IAG analysis suggests, as 75-second spots proliferate.
Rx ad spend down 7.8% for first half of 2009, says TNS
Matthew Arnold
September 16, 2009
US advertising spend for prescription drugs declined 7.8% to $2.3 billion for the first six months of 2009 over the same period in 2008, according to TNS Media Intelligence data.
DTC ads made some cancer patients doubt their docs
Matthew Arnold
August 17, 2009
A survey of patients at Harvard's Dana-Farber Cancer Institute found that 11% said ads for cancer-related drugs had made them less confident in their providers' judgment.
For Pristiq, Wyeth deploys wind-up doll
Matthew Arnold
June 10, 2009
Wyeth is cranking up consumer advertising for Pristiq with spots that aim to capture depression sufferers' struggle to get through the day, as represented by an iconic wind-up doll.
Last chance to grab glory
June 04, 2009
If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.
DTC spend set to slide, loyalty cards up, says survey
Matthew Arnold
May 13, 2009
Marketers anticipate substantial cuts in DTC spend in 2009, according to a Cegedim Dendrite survey in which 58% of respondents said they'd cut consumer ad spend this year. Last year 28% said they'd cut back on consumer advertising.
Rx TV ads more memorable in '08, Nielsen says
Matthew Arnold
April 02, 2009
TV ads for prescription drugs loosened up a bit in 2008 and exercised greater creativity despite intense scrutiny, The Nielsen Company found in a review of advertising recall rates for 2008.
Pharma US ad spend fell 18.4% in '08, says Nielsen
Matthew Arnold
March 13, 2009
Pharmaceutical industry ad spend fell 18.4% in 2008 to $4.3 billion in the US, according to The Nielsen Company. J&J, the sole drug company among the nation's top 10 advertisers, spent $1.2 billion on advertising -- a drop of 5.4% from 2007 spend.
As patients scrimp, BMS ads offer to pay Orencia co-pays
Matthew Arnold
March 11, 2009
Recession got you down? Having second thoughts about filling that prescription? How about some help with your co-pay? That's the tack Bristol-Myers Squibb is taking with its Orencia Promise program.
GSK ads for Avodart are misleading, says FDA
Ben Comer
March 03, 2009
Consumer ads in support of GSK's prostate drug Avodart overstate its efficacy and present misleading claims, the FDA said.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MM&M Awards Photos
Most Popular
Most Emailed
Most Recent
Elsevier begins outreach as push-back on publisher threatens to widen
Industry group releases digital best practices
Patient Education: Vying for Attention
Jobson Medical files for chapter 11 debt relief
P&G signals plans to cut ad costs by shifting to digital media
MM&M Therapeutic Focus: Cardiovascular
AstraZeneca announces more layoffs, Q4 results
Komen, caught up in the culture wars, nurses damaged brand
DDR on DTC: Spiriva
Merck results buoyed by sales of Januvia franchise
Jobson Medical files for chapter 11 debt relief
Elsevier begins outreach as push-back on publisher threatens to widen
Industry group releases digital best practices
P&G signals plans to cut ad costs by shifting to digital media
Merck results buoyed by sales of Januvia franchise
MM&M Therapeutic Focus: Cardiovascular
Merck, GSK shrug off rec to make HPV vaccine routine
Allergan scrubs some doc-payment data, spares med-ed grants
Patient Education: Vying for Attention
Headliner: Fred Wilkinson, Watson Pharmaceuticals
Pfizer promotes Canada chief to lead US primary care marketing
Pharma had third-most layoffs in Jan 2012
Amylin reports Q4 sales slump, touts Bydureon potential
Digital think tank: Pharma Touchpoints
Case study—Nuvigil: Pay for Play
Gamification: Game On
Regulatory updates: First Glimmer of Guidance?
Website development: 5 Steps to Walk the Web Walk
Mobile: Get Smart
Overview: A Movable Feast
Popular Topics
Adherence
Advertising
Approval
Brand
Corporate Reputation
DDMAC
Digital
Direct To Consumer (DTC)
DTC
Facebook
FDA
Generic
Guidance
Launch
Loyalty Program
Magazine
Major Statement
Manufacturing
Media
Medical Education
Off-label
Online
OPDP
Social Media
Television